Treatment

EAN guidance on managing patients with dementia

Medical management issues in dementia: recommendations

Therapeutic development in Alzheimer’s disease and the lack of funding

Identifying new therapeutic targets for neurodegenerative diseases

The future of Alzheimer’s disease: aducanumab

Hopeful developments for Alzheimer’s Disease

CT1812: exciting preliminary results

Therapeutics designed to mimic protective mutations for Alzheimer’s disease

The use of digital memory notebooks to improve memory impairment

Repurposing existing drugs to treat Alzheimer’s disease

The importance of early treatment and diagnosis of Alzheimer’s disease

The different care pathways for mild and severe Alzheimer’s disease

Alzheimer’s disease: balancing infection risk and mental well-being during the COVID-19 pandemic

Is the world prepared for dementia?

Alzheimer’s disease: what are the challenges when disease-modifying therapies become available?

Criteria for the diagnosis and management of dementia with Lewy bodies